These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 15238221)

  • 1. Human free apolipoprotein A-I and artificial pre-beta-high-density lipoprotein inhibit eNOS activity and NO release.
    Briand O; Nizard FM; David-Dufilho M; Six I; Lestavel S; Brunet A; Fruchart JC; Torpier G; Bordet R; Clavey V; Duriez P
    Biochim Biophys Acta; 2004 Jul; 1683(1-3):69-77. PubMed ID: 15238221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daidzein and 17 beta-estradiol enhance nitric oxide synthase activity associated with an increase in calmodulin and a decrease in caveolin-1.
    Woodman OL; Missen MA; Boujaoude M
    J Cardiovasc Pharmacol; 2004 Aug; 44(2):155-63. PubMed ID: 15243295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opposing effects of reactive oxygen species and cholesterol on endothelial nitric oxide synthase and endothelial cell caveolae.
    Peterson TE; Poppa V; Ueba H; Wu A; Yan C; Berk BC
    Circ Res; 1999 Jul; 85(1):29-37. PubMed ID: 10400908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic association of nitric oxide downstream signaling molecules with endothelial caveolin-1 in rat aorta.
    Linder AE; McCluskey LP; Cole KR; Lanning KM; Webb RC
    J Pharmacol Exp Ther; 2005 Jul; 314(1):9-15. PubMed ID: 15778264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-4F, an apolipoprotein A-1 mimetic, restores nitric oxide and superoxide anion balance in low-density lipoprotein-treated endothelial cells.
    Ou Z; Ou J; Ackerman AW; Oldham KT; Pritchard KA
    Circulation; 2003 Mar; 107(11):1520-4. PubMed ID: 12654610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 16K-prolactin inhibits activation of endothelial nitric oxide synthase, intracellular calcium mobilization, and endothelium-dependent vasorelaxation.
    Gonzalez C; Corbacho AM; Eiserich JP; Garcia C; Lopez-Barrera F; Morales-Tlalpan V; Barajas-Espinosa A; Diaz-Muñoz M; Rubio R; Lin SH; Martinez de la Escalera G; Clapp C
    Endocrinology; 2004 Dec; 145(12):5714-22. PubMed ID: 15358675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-density lipoprotein increases the abundance of eNOS protein in human vascular endothelial cells by increasing its half-life.
    Rämet ME; Rämet M; Lu Q; Nickerson M; Savolainen MJ; Malzone A; Karas RH
    J Am Coll Cardiol; 2003 Jun; 41(12):2288-97. PubMed ID: 12821261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase.
    Feron O; Dessy C; Moniotte S; Desager JP; Balligand JL
    J Clin Invest; 1999 Mar; 103(6):897-905. PubMed ID: 10079111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-density lipoprotein antagonizes oxidized low-density lipoprotein by suppressing oxygen free-radical formation and preserving nitric oxide bioactivity.
    Lee CM; Chien CT; Chang PY; Hsieh MY; Jui HY; Liau CS; Hsu SM; Lee YT
    Atherosclerosis; 2005 Dec; 183(2):251-8. PubMed ID: 16098532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of endothelial nitric oxide synthase through beta(2)-adrenergic receptor--the role of a beta-blocker with NO-releasing action.
    Jayachandran M; Hayashi T; Sumi D; Thakur NK; Kano H; Ignarro LJ; Iguchi A
    Biochem Biophys Res Commun; 2001 Jan; 280(3):589-94. PubMed ID: 11162560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidized low density lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal caveolae and impairs eNOS activation.
    Blair A; Shaul PW; Yuhanna IS; Conrad PA; Smart EJ
    J Biol Chem; 1999 Nov; 274(45):32512-9. PubMed ID: 10542298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of the endothelial nitric oxide synthase with the CAT-1 arginine transporter enhances NO release by a mechanism not involving arginine transport.
    Li C; Huang W; Harris MB; Goolsby JM; Venema RC
    Biochem J; 2005 Mar; 386(Pt 3):567-74. PubMed ID: 15743275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial derived vasorelaxation is impaired in human APO A-I transgenic rabbits.
    Lebuffe G; Boullier A; Tailleux A; Delfly B; Dupuis B; Fruchart JC; Duverger N; Emmanuel F; Denefle P; Vallet B; Duriez P
    Biochem Biophys Res Commun; 1997 Dec; 241(1):205-11. PubMed ID: 9405258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial nitric oxide synthase and its negative regulator caveolin-1 localize to distinct perinuclear organelles.
    Govers R; van der Sluijs P; van Donselaar E; Slot JW; Rabelink TJ
    J Histochem Cytochem; 2002 Jun; 50(6):779-88. PubMed ID: 12019294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of high-density lipoprotein particles containing apo A-I, with or without apo A-II, on intracellular cholesterol efflux.
    Oikawa S; Mendez AJ; Oram JF; Bierman EL; Cheung MC
    Biochim Biophys Acta; 1993 Jan; 1165(3):327-34. PubMed ID: 8418891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High density lipoprotein from patients with valvular heart disease uncouples endothelial nitric oxide synthase.
    Chang FJ; Yuan HY; Hu XX; Ou ZJ; Fu L; Lin ZB; Wang ZP; Wang SM; Zhou L; Xu YQ; Wang CP; Xu Z; Zhang X; Zhang CX; Ou JS
    J Mol Cell Cardiol; 2014 Sep; 74():209-19. PubMed ID: 24887036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genistein acutely stimulates nitric oxide synthesis in vascular endothelial cells by a cyclic adenosine 5'-monophosphate-dependent mechanism.
    Liu D; Homan LL; Dillon JS
    Endocrinology; 2004 Dec; 145(12):5532-9. PubMed ID: 15319357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caveolin-1 detergent solubility and association with endothelial nitric oxide synthase is modulated by tyrosine phosphorylation.
    Venema VJ; Zou R; Ju H; Marrero MB; Venema RC
    Biochem Biophys Res Commun; 1997 Jul; 236(1):155-61. PubMed ID: 9223444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release of nitric oxide from endothelial cells stimulated by YC-1, an activator of soluble guanylyl cyclase.
    Wohlfart P; Malinski T; Ruetten H; Schindler U; Linz W; Schoenafinger K; Strobel H; Wiemer G
    Br J Pharmacol; 1999 Nov; 128(6):1316-22. PubMed ID: 10578147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproic acid increases NO production via the SH-PTP1-CDK5-eNOS-Ser(116) signaling cascade in endothelial cells and mice.
    Cho DH; Park JH; Joo Lee E; Jong Won K; Lee SH; Kim YH; Hwang S; Ja Kwon K; Young Shin C; Song KH; Jo I; Han SH
    Free Radic Biol Med; 2014 Nov; 76():96-106. PubMed ID: 25150199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.